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Abstract
Gene expression quantitative trait loci (eQTL) are useful for identifying single nucleotide polymorphisms (SNPs) associated
with diseases. At times, a genetic variant may be associated with a master regulator involved in the manifestation of a
disease. The downstream target genes of the master regulator are typically co-expressed and share biological function.
Therefore, it is practical to screen for eQTLs by identifying SNPs associated with the targets of a transcript-regulator (TR). We
used a multivariate regression with the gene expression of known targets of TRs and SNPs to identify TReQTLs in European
(CEU) and African (YRI) HapMap populations. A nominal p-value of ,1610
26 revealed 234 SNPs in CEU and 154 in YRI as
TReQTLs. These represent 36 independent (tag) SNPs in CEU and 39 in YRI affecting the downstream targets of 25 and 36
TRs respectively. At a false discovery rate (FDR)=45%, one cis-acting tag SNP (within 1 kb of a gene) in each population was
identified as a TReQTL. In CEU, the SNP (rs16858621) in Pcnxl2 was found to be associated with the genes regulated by
CREM whereas in YRI, the SNP (rs16909324) was linked to the targets of miRNA hsa-miR-125a. To infer the pathways that
regulate expression, we ranked TReQTLs by connectivity within the structure of biological process subtrees. One TReQTL
SNP (rs3790904) in CEU maps to Lphn2 and is associated (nominal p-value=8.1610
27) with the targets of the X-linked
breast cancer suppressor Foxp3. The structure of the biological process subtree and a gene interaction network of the
TReQTL revealed that tumor necrosis factor, NF-kappaB and variants in G-protein coupled receptors signaling may play a
central role as communicators in Foxp3 functional regulation. The potential pleiotropic effect of the Foxp3 TReQTLs was
gleaned from integrating mRNA-Seq data and SNP-set enrichment into the analysis.
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Introduction
Phenotypic differences between populations have been shown to
be associated with variation in genes, the epigenome, the
environment and quantitative traits. Gene expression has been
used as a quantitative phenotypic trait to locate regions in the
genome that have polymorphisms governing differential transcrip-
tion within populations [1,2,3,4]. This type of inference termed
expression quantitative trait loci (eQTL) analysis has been used in
genome-wide association studies (GWAS) to map single nucleotide
polymorphisms (SNPs) to regions that affect gene expression [5].
Recently it has been shown that SNPs associated with a
phenotypic trait are more likely to be eQTLs [6]. The advantage
of understanding the contribution of genetic variations on the
expression of genes has major implications on the manner in
which pharmaceuticals are personalized for an individual and how
complex diseases are investigated.
A typical eQTL approach entails modeling the expression of a
single gene as a response variable with the genotypes of a single
SNP as the predictor variable. Variants of eQTL modeling take
the form of a pathway, network component, sparse factor, cluster
or the average of a group of co-expressed genes as the response
variable and/or predict the expression according to a set of SNPs
selected by LASSO, canonical correlation or interval mapping
[7,8,9,10,11,12,13,14]. The goal is to determine if there are
‘‘eQTL hotspots’’ [15] where a SNP leads to widespread changes
in the expression of genes that are coordinately regulated.
Hallmark examples of the power of eQTL analysis for determi-
nation of population differences are illustrated by several recent
bodies of work. For example, several investigators have demon-
strated the robustness of eQTLs to discern variation in gene
expression between populations due to environmental exposures
or geographic ancestry [16,17,18,19]. Others have shown that
gene expression can vary according to particular genotypes,
chemical agents and factors such as tissue type, gender, genotype
and age [20,21,22,23,24,25]. Also, many have successfully linked
genetic variants to transcriptional patterns within ethnic groups
[26] although batch effects and biological noise confounding the
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of the results [27,28]. For instance, the SCAN database [29] is a
catalogue of the association of a given SNP to variations in gene
expression between Yoruba in Ibadan, Nigeria (African: YRI) and
CEPH-Utah residents with ancestry from northern and western
Europe (European: CEU) HapMap populations [30]. These
variants can be cis-o rtrans-acting whereby the effect is situated
proximal to the expressed gene or it is located elsewhere in the
genome, respectively. Although it has been suggested that SNPs
residing in transcription factors (TFs) have no significant
attributable effect on gene expression variation [11], it is unknown
whether a variant that affects the genes regulated by a TF operates
through a system of regulated pathways. Therefore, a more
comprehensive way to better understand the genetic component of
variation in gene expression within and between populations is to
address the problem on a systems biology level. In other words, on
a genome-wide scale, simultaneously model the expression of
genes that are downstream targets (DSTs) of a transcript-regulator
(TR) (Figure 1). A TR can be a TF, a cofactor, a complex, a
microRNA or combination of these which are involved in the
regulation of transcription and govern signaling pathways.
Li et al. [9] demonstrated the practicality of utilizing pathways
as a response variable to associate SNPs between two genotype
categories. They identified several genome-wide pathway regula-
tors that seem to mediate gene expression differences. The
advantages of this type of TReQTL approach are that the
covariance of the DSTs is used in the modeling, co-regulation of
the genes is inferred and the eQTL scan is genome-wide. Hence,
scanning for TReQTLs is more likely to reveal variants that confer
differences in gene expression between populations through
genetically-wired regulatory mechanisms. We used a multivariate
linear regression to model the DSTs of TRs with SNPs typed in
CEU and YRI populations. The DSTs of the TRs were obtained
from the TRANSFACH knowledgebase - a biological resource that
catalogs experimentally-proven binding and regulation of genes by
various TRs [31,32]. For all TRs with two or more DSTs, we
detected 234 SNPs in CEU and 154 in YRI representing 36 and
39 independent (tag) SNPs as TReQTLs and affecting the DSTs of
25 and 36 TRs respectively. The expression of the DSTs of 24
TRs was associated with SNPs in both populations. Mapping to
within 1 kb of a gene and controlling for multiple testing revealed
one cis-acting tag SNP in each population as a TReQTL. In CEU,
a TReQTL SNP was found to be associated with the DSTs of the
X-linked breast cancer suppressor Foxp3 but is not significant in
the YRI dataset. The Foxp3 TReQTL SNPs were overrepresent-
ed in evolutionary conserved regions (ECRs) of the genome in
CEU and enriched in splice junctions (SJs) in YRI.
Results
Analysis Strategy
Typical expression quantitative trait loci (eQTL) analyses take
the form of a strategy where a single gene is used as a response
variable and individual single nucleotide polymorphisms (SNPs)
the predictor variable to determine if there is association of a
particular phenotype with a variant. The correlation of co-
regulated genes is not taken into consideration. We used a
multivariate approach to leverage the covariance of the gene
expression of downstream targets (DSTs) of a transcript-regulator
(TR) to perform genome-wide associations for SNPs that are
potentially linked to changes in gene expression across genotypes.
The genotype data (phase-II, release 24, forward strand, non-
redundant) from the 60 Yoruba in Ibadan, Nigeria (African: YRI)
and from the 60 CEPH-Utah residents with ancestry from
northern and western Europe (European: CEU) populations were
obtained from the International HapMap Project [30]. Gene
expression data from the profiling of Epstein-Barr virus (EBV)-
transformed lymphoblastoid cell lines from the individuals in each
CEU and YRI HapMap population [33] were obtained from the
National Center for Biotechnology Information Gene Expression
Omnibus (GEO) database under accession number GSE10824.
Figure 1 illustrates that using this model, TReQTLs can be
identified which are associated with the downstream targets of
TRs. The genetic variation attributed to the association are
imbedded, and therefore discovered in the network of regulatory
pathways that govern the co-regulation behind the phenotypic
trait. The TReQTLs may be within a single gene (cis), spread
across several genes (trans) or located in regions of unknown
biological function. In addition, the case may be that several
TReQTLs for the DSTs of TRs may share the same variants or
portions of the same variants. To investigate the regulatory
component of TReQTLs, we first sort out to determine if two
populations (YRI and CEU) had shared or varied signaling
transduction mechanisms robust enough for a more refined
association analysis.
Figure 1. Strategy to identify transcript-regulator eQTLs (TReQTLs). The gene expression of downstream targets (DSTs) of a transcript-
regulator (TR) is used as quantitative traits to associate with individual single nucleotide polymorphisms (SNPs). In some cases the SNPs map to the
same gene, different genes, the TR or are intergenic.
doi:10.1371/journal.pone.0034286.g001
Population Differences in TReQTLs
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Using the TRANSFAC [31,32] and TRANPATH [34]
databases of components of signal transduction and regulatory
pathways respectively, 2,743 TRs were mapped from the
approximately 9,000 probe sets on the Affymetrix Human HG-
Focus Target GeneChip Array, 1,438 signaling pathways were
identified as comprised of at least one of the TRs and 78 TRs were
mapped to one or more pathways. As shown in Figure 2, 333 TRs
were determined to have two or more DSTs. These regulate 1,931
DSTs. The TRs consist of transfactors (TFs), cofactors, complexes
and miRNAs. Three TFs, all stimulating proteins (Sp), regulate
more than 60 DSTs. The median value for the TR DSTs is 3 and
the mean is 5.8.
Significant Signaling Transcript-regulators of Individual
Populations
To determine the extent of co-regulation of genes within CEU
and YRI populations, the correlation of the gene expression of
pairs of the genes which are DSTs of TRs was assessed.
Significance (p-value,or<0.05) was determined from a non-
parametric distribution of correlation scores obtained from 10,000
random cases. The correlation score is the sum of the squares of
the Pearson correlations (r) among all pairs of genes determined to
be DSTs of a TR (see the Materials and Methods section for more
detail). For illustrative purposes, Table 1 reports the significance of
the correlation of DSTs of only those TRs where disease-causing
SNPs are located in the TR target site. The disease-causing SNPs
were obtained from the NHGRI GWAS Catalog (www.genome.
gov/gwastudies) and mapped to the TRANSFAC position weight
matrix consensus sequence for the binding of at least one of the
DSTs of the TR. Interferon-stimulated gene factor 3 (ISGF3), X-
box binding protein 1 (XBP1) and hepatocyte nuclear factor 4-
alpha (HNF4-a) are significant in the CEU and YRI populations.
Signal transducers and activators of transcription 21 (STAT1),
activating transcription factor 1 (ATF1) and peroxisome prolif-
erator activating receptor gamma (PPAR-c) are significant in YRI
only whereas upstream transcription factor 1 (USF1), the Sp1:Sp3
complex and the retinoid X receptor alpha (RXR-a):PPAR-c
complex are significant in CEU only.
Genome-wide Analysis for Transcript-regulator
Expression Quantitative Trait Loci
To search for eQTLs that are tied to genes which are co-
regulated in a given population, a multivariate linear regression
was used to model the gene expression of the DSTs of TRs as
response variables and the genotypes of SNPs as the predictor
variables. The analysis was restricted to i) the 333 TRs which were
found in the TRANSFAC database to have two or more DSTs
(1,931 of the 8,399 unique UniGene transcripts represented by
probe sets on the microarrays) and ii) to approximately 1.5 million
SNPs on the autosomal chromosomes that passed the filtering
criteria (see Materials and Methods) and were in common between
CEU and YRI (common set), the 416,160 SNPs among the 1.5
million common set at a minor allele frequency (MAF).=0.05
and linkage disequilibrium (LD) r
2.0.5 (tag set) and the 184,616
independent (tag) SNPs which are within 1 kb of a gene (cis-acting
set). For multiple testing correction, we used the 6.1610
7 p-values
from the cis-acting set to control the false discovery rate
(FDR=45%). For the three TRs with 60 or more DSTs, the
modified F-statistic [9,35,36] was used to obtain the nominal p-
value for the TReQTL. A preliminary analysis considered a
nominal p-value less than 1610
26 for detecting TReQTLs.
Although this cut-off is extremely high and subject to many false
positives, we were initially interested in the overall robustness of
the method to screen for putative associations. As illustrated in
Figure 3, the TReQTLs for the CEU and YRI populations are
widely different with 234 and 154 SNPs detected in CEU and YRI
respectively. These represent 36 tag SNPs in CEU and 39 in YRI
affecting the DSTs of 25 and 36 TRs respectively (Supplemental
Materials Table S1). None of the TReQTL SNPs in the two
populations overlap. At an FDR of 45%, two cis-acting tag SNPs
(one in each population) are considered TReQTLs. In CEU, the
SNP (rs16858621) in the pecanex-like 2 (Pcnxl2) gene was highly
associated with the DSTs of the cAMP responsive element
modulator (CREM) transfactor whereas in YRI, the SNP
(rs16909324) was linked to the targets of miRNA hsa-miR-125a.
As shown in Figure 4, there are a few cases where the SNPs are
mapped relative to a TR (i.e.,2 Mb). In CEU, the DSTs of TRs
alpha-CBF (T00081) and ENKTF-1 (T00255) possessed 13 and 4
TReQTL SNPs respectively but are not displayed as these DST
genes have not been characterized and hence, have no genomic
location. Four tag SNPs were associated with the DSTs of the
HIF2A:arnt complex (T10852) in CEU whereas 2 tag SNPs were
associated with the DSTs of miRNA hsa-miR-125a (T09819) in
YRI. Interestingly, in CEU, one tag SNP (rs16858621) was
associated (p-value,5610
27) with the DSTs of miRNA has-miR-
15a (T09712) and TF CREM (T01803) both of which regulate
Ccnd1 [37,38]. Thus, presumably, this represents a case where a
SNP may affect a master regulator that controls not only a TF but
a miRNA as well both of which share the role of regulating a
common gene. In YRI, there are several cases where a tag SNP is
associated with the DSTs of more than one TR. Although several
sets of DSTs of TRs were found to have a fair number of
significant tag SNPs mapped to them, two miRNAs (hsa-let-7e
(T09710) in CEU and hsa-miR-200a (T09837) in YRI) have
hotspots (SNPs in a region affecting multiple transcripts [15])
associated with the variation of expression of their DSTs according
to the genotypes at the alleles. When restricting the comparison of
the populations to the ,1.5 million SNPs in common, several of
the TReQTL overlapped between CEU and YRI. The expression
Figure 2. Distribution of the number of genes as downstream
targets (DSTs) of transcript-regulators. The x-axis is the # of
genes as DSTs and the y-axis is the count. The table inset is a summary
of the frequency distribution for the count of the DSTs (two or more)
per TR.
doi:10.1371/journal.pone.0034286.g002
Population Differences in TReQTLs
PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e34286Figure 3. Manhattan plot displaying distribution of TReQTLs. The x-axis is the relative position of the SNPs across the genome in Mb. The
chromosomes are illustrated by alternating shaded and unshaded sections of the plot. The order of the chromosomes is from #1t o#22 from left to
right. The y-axis represents the –log10 p-value of the SNP association with the gene expression of DSTs of the TRs. p-values of SNPs from CEU are
denoted as red circles, p-values of SNPs from YRI are denoted as green triangles. For visualization purposes, only SNPs having a p-value,0.002 in any
of the 333 TRs are plotted.
doi:10.1371/journal.pone.0034286.g003
Table 1. Co-regulation of DSTs of TRs where disease-causing SNPs are located in the TR binding site of at least one of the TR DSTs.
TR ID TR Symbol # of DSTs CEU GCS CEU p-value YRI GCS YRI p-value
T00428 ISGF-3 3 0.796 0.0055 0.328 0.0532
T00221 E2F:DP 7 1.374 0.3006 1.463 0.0629
T00902 XBP-1 2 0.565 0.0009 0.533 0.0001
T09484 NF-E2p45 4 1.148 0.0073 0.427 0.1163
T09998 c-Myc 3 0.541 0.0276 0.284 0.0821
T01804 NF-YA 13 6.222 0.0766 4.749 0.0482
T04759 STAT1 11 2.076 0.9201 3.452 0.0482
T09328 usf1 6 1.769 0.0268 0.607 0.4227
T10359 sp1:sp3 2 0.252 0.0316 0.064 0.2137
T00167 ATF-2-xbb4 3 0.078 0.7219 0.073 0.6045
T03828 HNF-4alpha 12 6.445 0.0187 4.570 0.0222
T04870 MafG 2 0.284 0.0250 0.300 0.0062
T00968 ATF-1 4 0.544 0.1565 0.564 0.0459
T05351 PPARgamma 2 0.193 0.0660 0.184 0.0339
T08618 RXR-alpha:PPARgamma 2 0.237 0.0395 0.006 0.7065
GCS – Group correlation score. The disease-causing SNPs were obtained from the NHGRI GWAS Catalog (Available at: www.genome.gov/gwastudies. Accessed 3/3/
2010) with selected SNP-trait associations limited to those with p-values,1610
25.
doi:10.1371/journal.pone.0034286.t001
Population Differences in TReQTLs
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populations (Table 2). These were SNPs mapped within or in
proximity to genes involved in transcription regulation, cell
communication, transport, kinase activity, growth and develop-
ment. Interestingly, several of the TReQTL SNPs in CEU are
mapped to pseudogenes.
Cohesive TReQTL Biological Process Subtrees Reveal
Descriptive Molecular Events
Each TReQTL is comprised of a SNP, a TR and a set of DSTs.
Each constituent is associated with a gene. We mapped the
constituents, except for cases where the TR is a miRNAs, to genes
and then determined the GO biological process term each was
annotated to. The collection of terms was then used to construct a
GO biological process subtree. All ancestors of a term were
included in the subtree. Our adjusted cohesion score (ACS) is an
ad hoc way to i) measure the amount of connectivity between
terms, ii) account for the significance of the TReQTL and iii)
consider the average number of paths per term. As listed in
Table 3, the top ranked TReQTLs have the more cohesive
subtrees and are more descriptive with respect to the term with
most paths associated with it (The full list is in supplemental
material Table S2 (CEU) Table S3 (YRI)). These associations
within the subtree can lead to new insight into the possible role of
the TReQTL SNP in the pathophysiology of diseases. For
instance, in YRI, the rs12258754 allelic variant is associated with
the DSTs of activating transcription factor 3 (Atf3) and produced a
subtree with vascular smooth muscle cell (VSMC) contraction as
the granular biological process node (Figure 5A). Interestingly, in
CEU, four SNPs associated with the variation of expression for the
DSTs of miRNAs hsa-mir-181b-1 (MI0000270) and hsa-mir-
181b-2 (MI0000683) are mapped to the peptidyl-prolyl cis-trans
isomerase A-like pseudo-gene and generated a subtree with
synaptic transmission as the most descriptive biological process
term (Figure 5B).
TReQTL interaction network
Many of the variants map to Online Mendelian Inheritance in
Man (OMIM) associated disease genes (data not shown). For
instance, one TReQTL in the CEU population is associated with
the DSTs of the X-linked breast cancer suppressor gene Foxp3
(T04280) transfactor [39]. Foxp3 belongs to the Forkhead box
family of genes, is located on chromosome X and is essential for
the production and normal function of regulatory T-cells. As
shown in Figure 6, interleukin 2 (Il2) and colony stimulating factor
2( CSF2), the DSTs of Foxp3, are two cytokines whose gene
expression co-regulation (correlation=0.56) is significantly associ-
ated with the variants of tag SNP rs3790904 (p-value=8.1 10
27)
which maps to the latrophilin homolog 1 (Lphh1/Lphn2) G-protein
couple receptor (GPCR) gene. This association is not significant in
YRI (p-value=0.89). Other significant SNPs in CEU that are
linked to the DST of Foxp3 map to an additional GPCR gene
(Lphn3) as well as a membrane ion channel (KCNJ1), a
phosphatidic acid phosphatase type 2 enzyme (Ppapdc1a) and an
uncharacterized gene. An interaction network of Foxp3, its DSTs
and genes that the TReQTLs map to revealed tumor necrosis
factor (TNF) and NF-kB as central hubs along with carcinoem-
bryonic antigen-related cell adhesion molecule 3 (CEACAM3),
Tgf-beta, and hepatocyte growth factor (HGF) as connectors
(Figure 7). Interesting enough, negative regulation of NF-kappaB
TF activity, cAMP response element-binding (CREB) activity and
T-cell cytokine production/positive regulation of regulatory T-cell
differentiation are biological processes within the Foxp3 TReQTL
subtree that are highly connected (Data not shown).
Over-representation of the Foxp3 TReQTL SNPs in
Genomic Regions
SNPs in multi-species/evolutionary conserved regions (ECRs)
may imply similarity of function across species [40] and those
within splice junctions (SJs) or splicing enhancers may play a role
in gene expression regulation through exon splicing [21,41] . In
other words, genetic variants that are related to gene expression
differences between populations are more likely to be in genomic
regions conserved across species and/or possibly involved in
regulating transcription by altering splice forms of transcript
messages. As an anecdotal example, we used 472 SNPs from the
union of the Foxp3 TReQTL SNPs between CEU (n=233) and
YRI (n=239) with a more liberal nominal p-value threshold
,1610
24 to determine over-representation within ECRs and SJs.
As displayed in Table 4, using SNP-set enrichment analysis [42],
the SNPs are significantly over-represented in 5-way ECRs for
CEU (p-value=0.006) but not YRI (p-value=0.9) and enriched in
SJs for YRI (p-value=1610
24) but not CEU (p-value=0.9). Fisher
exact tests confirm significance of the over-representation of these
TReQTL SNPs in 5-way ECRs for CEU (p-value=0.0079) and in
SJs for YRI (p-value=0.0001).
Discussion
Genetic and transcriptional variations are important key factors
in the evolution of biology and the dispensation of diseases. Single
nucleotide polymorphisms (SNPs) are one type of DNA sequence
alteration that is commonly used as a marker for tracking genetic
variation. The allelic frequency of a SNP at a given locus can vary
between populations and the genotype may code for a SNP that
results in a particular phenotype, trait or disease [43,44,45,46].
Within populations and under certain biological conditions genes
are coordinately regulated by transcript-regulators (TRs) such as
transcription factors (TFs), cofactors, complexes of TFs and
miRNAs (Table 1). These co-expressed genes often times share
biological functions and work in concert to mediate cellular events
such as biological processes and molecular pathways. Although it
has been shown that TFs do not harbor trans-acting variants [11],
coupling coordinately regulated genes as a quantitative trait for a
loci (eQTL) with the genotype of SNPs as a genome-wide
association study (GWAS) can presumably help to elucidate
variation in gene expression (TReQTLs) on a genomic and
systems biology scale that code for particular phenotypes and
complex diseases [9].
Tailoring the GWAS eQTL analysis by considering genes with
coordinated expression is of added value to reveal master
regulators of transcriptional genetic variation (Figure 1). We used
a multivariate linear regression with the gene expression of known
downstream targets (DSTs) of TRs (Figure 2) as the response
variable and individual SNPs as predictor variables to identify
TReQTLs in European (CEU) and African (YRI) HapMap
populations. At a nominal p-value threshold of ,1610
26 we
discovered 234 SNPs in CEU and 154 in YRI as putative
TReQTLs (Figure 4). These represent 36 and 39 independent (tag)
SNPs in CEU and YRI affecting the DSTs of 25 and 36 TRs
respectively. Two SNPs (one in each population) are cis-acting
TReQTLs (within 1 kb of a gene) at a false discovery rate (FDR) of
45%. One of them, a SNP in the pecanex-like 2 (Pcnxl2) gene was
found in CEU to be highly associated with the DSTs of the cAMP
responsive element modulator (CREM) transfactor whereas in the
YRI dataset, a SNP was linked to the DSTs of miRNA hsa-miR-
125a. Although the FDR may seem abnormally high and one
would expect at least one if not both of the TReQTLs to be false
positives, it can be misleading as others have demonstrated that
Population Differences in TReQTLs
PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e34286Figure 4. Dot plot of significant TReQTLs. A) CEU B) YRI. Each circle represents a TReQTL SNP with a p-value,1610
26. The x-axis is the relative
position of the TReQTL SNPs across the genome in Mb. The chromosomes are illustrated by alternating shaded and unshaded sections of the plot.
The order of the chromosomes is from #1t o#22 from left to right. The y-axis is the relative position of the TR across the genome in Mb. The order of
the chromosomes is from #1t o#22 from bottom to top. The points were jittered to enhance the display of TReQTLs in close proximity. TReQTLs
near the diagonal line have the potential to be cis-regulated.
doi:10.1371/journal.pone.0034286.g004
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is a major challenge and a substantial overestimation of the
number of false positives [47,48,49].
Interestingly enough, the gene expression of the DSTs of 24
TRs was associated with SNPs (albeit different ones) in both
populations (Table 2) but the majority differed (Figures 3 and 4).
The overlap in the TReQTLs probably reflects the ubiquity of
certain basic biological processes such as transcription regulation,
cell communication, transport, kinase activity, growth and
development. On the otherhand, one TReQTL tag SNP
(rs3790904) in the CEU population is associated (p-val-
ue=8.1610
27) with the DSTs of the X-linked breast cancer
suppressor gene Foxp3 (Figure 6) but is not significant in YRI (p-
value=0.89). The interaction network of the Foxp3 TReQTL in
CEU revealed that tumor necrosis factor (TNF), NF-kappaB and
variants in G-protein coupled receptors (GPCR) signaling may
play a central role as communicators in Foxp3 functional
regulation (Figure 7). Although the Foxp3 tumor suppressor is
biologically relevant in the pathogenesis of breast cancer, some
have shown that SNPs in the germline of the gene are not
associated with the risk of the disease [50]. Our TReQTL analysis
reveals other potentially interesting loci which might be causative
in the etiology of complex diseases.
Another difference between the two populations based on the
TReQTLs was the connectivity of the underlining Gene Ontology
(GO) biological processes that the genes of the TReQTL represent
(Figure 5). In CEU, several SNPs associated with the variation of
expression for the DSTs of two miRNAs (hsa-mir-181b-1
(MI0000270) and hsa-mir-181b-2 (MI0000683)) are mapped to
the peptidyl-prolyl cis-trans isomerase pseudo-gene and yields a
subtree with synaptic transmission as the more cohesive descriptive
GO term (Table 3). The activity of this enzyme has been suggested
to be necessary for memory formation and may be involved in
complex neurodegenerations such as Alzheimer’s disease [51]. In
YRI, a SNP (rs12258754) controlling the variation of expression
for the DSTs of activating transcription factor 3 (Atf3) yielded a
subtree with vascular smooth muscle cell (VSMC) contraction as
the more descriptive GO term (Table 3). Although much is not
currently known about the function of Atf3 in VSMCs [52],
mutations in the actin, alpha 2 (Acta2) smooth muscle gene have
been shown to result in a variety of vascular diseases [53].
Transcriptional networks such as these have been recently shown
to be hubs with high connectivity and association with controlling
higher-ordered biological function such as lipogenesis, lipid
trafficking and surfactant homeostasis [54]. Our approach
embraces this strategy by using the SNPs within the TReQTLs
as an adjudicator for the identification of master regulators of these
genetic networks. Although it is expected that a TR and its DSTs
will share a common signaling pathway, what is not certain is that
the SNP associated with the eQTL from the TR and DSTs will
reside near or in a gene with biological functionality that forms a
cohesive GO biological process subtree. Bear in mind that it is not
known where the true regulating TR associated with a candidate
TReQTL actually exerts its biological functionality and to date,
there is no independent data set with gene expression and
genotype calls from another sample of the YRI and CEU
Table 2. TRs in common between CEU and YRI TReQTLs.
TR ID TR Symbol CEU SNP Gene ID CEU SNP Gene Symbol CEU SNP YRI SNP Gene ID YRI SNP Gene Symbol YRI SNP
T00250 Elk-1 rs9838549 131185 LOC131185 rs965676 6638 SNRPN
T00255 ENKTF-1 rs10510093 2263 FGFR2 rs6864839 4488 MSX2
T00498 alpha-enolase rs1029741 54543 TOMM7 rs12358485 359779 MRPS35P3
T00902 XBP-1 rs11686328 129563 DIS3L2 rs6111734 27131 SNX5
T00910 YB-1 rs17586344 1956 EGFR rs11120212 100505832 LOC100505832
T01814 pax6-isoform5a rs3212243 11035 RIPK3 rs10755971 137902 PXDNL
T01931 RelB rs9610774 29775 CARD10 rs289838 9111 NMI
T02689 GATA-6 rs13345832 55769 ZNF83 rs2937889 57509 MTUS1
T04870 MafG rs1153303 150000 ABCC13 rs12691592 53353 LRP1B
T04953 TFIIIA rs11692860 729009 FTH1P20 rs7755681 5071 PARK2
T04959 GKLF-isoform1 rs9484664 100420742 LOC100420742 rs16848653 55137 FIGN
T04996 ZBP89 rs6691852 467 ATF3 rs6549604 5067 CNTN3
T05324 LXR-alpha:RXR-alpha rs11157248 6955 TRA-alpha rs7072859 2894 GRID1
T06135 p63gamma rs6670238 51018 RRP15 rs1558561 9717 SEC14L5
T08465 C/EBPalpha rs9068 220988 HNRNPA3 rs6570819 23328 SASH1
T08618 RXR-alpha:PPARgamma rs1331584 150928 PTMAP5 rs4596085 11280 SCN11A
T09159 pitx2a rs1983600 9742 IFT140 rs6966461 154664 ABCA13
T10331 NRF-1 rs7272098 6238 RRBP1 rs1347038 2043 EPHA4
T10852 HIF2A:arnt rs2741270 248 ALPI rs28740902 4487 MSX1
T11264 CP2 rs1020344 100130101 LOC100130101 rs3819726 4121 MAN1A1
T13796 TLS rs10143078 55333 SYNJ2BP rs870181 55275 VPS53
T14942 hsa-miR-181b rs17543080 392285 LOC392285 rs10797531 148641 SLC35F3
T15206 N-Myc rs2268943 4070 TACSTD2 rs1181164 148979 GLIS1
T15913 RXR-alpha:NR1B1 rs1855625 643954 RPSAP43 rs17238405 4734 NEDD4
doi:10.1371/journal.pone.0034286.t002
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data from Idaghdour et al. [16] are made publicly available, we
will be able to use it to determine if our TReQTLs can discern
between Moroccan populations according to geographical loca-
tions, regional differences and ancestry. Furthermore, in depth
functional analyses on TR targets will presumably shed light on
these TReQTL regulatory networks and perhaps biologically
confirm our results.
McCauley et al. [40] reported that SNPs in multi-species
conserved sequences (MCS) are useful as markers linking to
complex diseases.Recentevidence suggeststhatSNPs that influence
alternative splicing are enriched within splice junctions (SJs) or
disrupt splicing enhancers [21,41]. Our analysis of Foxp3
TReQTLs revealed SNPs overrepresented within 5-way (human,
mouse, chimp, rhesus monkey and dog) evolutionary conserved
regions (ECRs) in CEU and in SJs of YRI defined by RNA-Seq
mapping (Table 4). These results support the notion that genomics,
genetics and transcriptomics play an intricate role in sustaining
population diversity and structure [16]. It would be interesting to
determine how environmental factors, population structure and
geographical differences affect transcript abundance as a quantita-
tive trait when co-regulation of gene expression is considered.
Although the identification of TReQTLs is useful for deter-
mining genetic variants regulating gene expression, there are
limitations to the approach and guidelines with interpretation of
the results. First, there is a paucity of information about the genes
which TRs control. We restricted our analysis to only 333 TRs
with two or more DSTs known at a given time to be regulated by
TRs. This does not capture the full array of genetic variants which
might contribute to the gene expression differences between the
two populations. However, as advances in functional genomics
leads to improved knowledge about gene regulation and biological
function on a genome-wide scale, the discovery of TReQTLs
should advance and be more informative. In addition, the study of
the transcript-regulation of genes by miRNA is in its infancy and
there is a small number of miRNAs known to regulate genes.
Furthermore, our analysis only tested the association of a single
SNP with sets of coordinately expressed genes. It is very likely that
the variation in expression is due to the synergistic effect of two or
more SNPs. In fact, there may be other mediators of complex
diseases other than SNPs acting alone or symbiotically. Finally,
our work relied on samples from immortalized lymphoblastoid cell
lines (LCLs) and not from a disease state. Therefore, it is debatable
whether or not the genetic associations of SNPs with gene
expression in LCLs will carry over to tissue samples from organs
[55]. However, there is some indication, albeit a paucity of
evidence, that the DNA repair capacity of LCLs from breast
cancer samples is significantly lower than control subjects [56],
that tumor-infiltrating Foxp3+ regulatory T cells can distinguish
between high-risk breast cancer patients and those at risk of a late
relapse [57] and that a fraction of eQTLs derived from the analysis
of UK Adult Twin registry LCLs gene expression and genotype
data overlap with those identified in a HapMap population [47].
Despite the caveats noted above, the advantages of associating
genetic markers such as SNPs to quantitative traits such as co-
regulated genes is promising and of value as an additional strategy
when investigating the role of a genetic variant and master
regulators in the etiology of a complex diseases.
Materials and Methods
Genotype Data
Genotype data (phase-II, release 24, forward strand, non-
redundant) from the 60 Yoruba in Ibadan, Nigeria (African: YRI)
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PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e34286and from the 60 CEPH-Utah residents with ancestry from
northern and western Europe (European: CEU) populations were
obtained from the International HapMap Project [30]. SNPs with
a call rate ,95%, minor allele frequency (MAF),0.05, or Hardy-
Weinberg equilibrium [58] p-value,0.05 within each population
separately were removed and we restricted our analysis to
autosomal markers only. About 2 million SNPs in CEU and
,2.2 million SNPs in YRI were retained after filtering. The
approximately 1.5 million SNPs in common between the two
populations after filtering (common set) were used for TReQTL
preliminary analysis using a nominal p-value threshold of
,1610
26. To account for correlated SNPs, we used the LRTag
approach [59,60] with linkage disequilibrium (LD) correlation
(r
2).0.5 and MAF.=0.05 to tag 416,160 independent SNPs (tag
set) of the 1.5 million in the common set. In addition, for multiple
testing correction, we used the p-values of the tag SNPs that are
within 1 kb of a gene (cis-acting set) to obtain an FDR. For the
SNP association portion of the study, we focused the sample set on
the 60 CEU and 55 YRI individuals that had corresponding gene
expression data.
Figure 5. TReQTL Gene Ontology (GO) biological process subtrees. A) Based on the GO biological processes from the gene that the YRI
TReQTL SNP rs12258754 map to and those of the DSTs of activating transcription factor 3 (Atf3) and of Atf3 itself. B) Based on the GO biological
processes from the gene that the CEU TReQTL SNP rs10976413 map to and those of the DSTs of miRNAs hsa-mir-181b-1 (MI0000270) and hsa-mir-
181b-2 (MI0000683).
doi:10.1371/journal.pone.0034286.g005
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PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e34286Microarray Gene Expression Data
Gene expression data from the profiling of Epstein-Barr virus
(EBV)-transformed lymphoblastoid cell lines from the individuals
in each CEU and YRI HapMap population were acquired from
assaying total RNA on Affymetrix Human HG-Focus Target
GeneChip Array [33] containing about 9,000 probe sets and
representing about 8,600 UniGenes (NetAffx array annotation
release 29, March 30, 2009 UniGene build 219). The data are
available in the National Center for Biotechnology Information
(NCBI) Gene Expression Omnibus (GEO) database [61,62] under
accession number GSE10824. The data were log2 transformed
and normalized using the robust multi-array average method [63].
The gene expression data from probe sets that mapped to the same
UniGene cluster were averaged resulting in 8,399 unique
UniGene transcripts represented by probe sets on the array.
RNA-Seq Data
We obtained raw sequence reads from the whole transcriptome
sequencing of the CEU and YRI populations [64,65]. These reads
were mapped to the reference human genome (hg18, NCBI 36)
using the Bowtie program [66]. Splice junctions (SJs) were
mapped using the Tophat program [67]. Transcript abundance
was calculated by the Cufflinks program [68] and normalized
using the FPKM (Fragment Per Kilobase of Exon per Million
reads) method [69]. At a nominal p-value,1610
24 there are a
total of 7,149 and 7,040 TReQTL SNPs in the CEU and YRI
populations respectively. Each SNP was evaluated for its presence
in SJs in each individual from both populations. The total number
of SNPs in each population was calculated based on their presence
or absence in any individual of the population.
Signal Transduction Pathway Profiling
The Affymetrix GeneChip array probe sets were collapsed into
approximately 8,600 UniGene transcript clusters using the March
30, 2009 release of UniGene (build 219). The gene expression data
from probe sets that mapped to the same UniGene cluster were
averaged resulting in 8,399 UniGene transcripts. The UniGene
downstream targets (DSTs) of transcript-regulators (TRs: tran-
scription factors (TFs), miRNAs, cofactors and complexes) were
obtained from the March 26, 2010 release (version 2010.1) of the
TRANSFACH database [31,32]. TRs were mapped to signaling
pathways using the June 26, 2009 release (version 2009.2) of the
TRANSPATHH database [34]. Significance of signal transduction
pathway profiling was determined as previously described [70].
Briefly, for each population individually, significant TRs were
based on a Group Correlation Score
GCS~
X
i=j
r2
i,j ð1Þ
defined as the sum of the squares of the Pearson correlations (r)
among all pairs of genes i and j determined to be DSTs of the TR.
Significant pathways made up of TRs are based on an Exclusive
Group Correlation Score
EGCS~
X
TR i ðÞ \TR j ðÞ ~0
r2
i,j ð2Þ
defined as the sum of the squares of r over all pairs of genes i and j
in a pathway that do not share any TR. This eliminates the
contribution of the co-expression of DSTs that share TRs. The p-
Figure 6. Scatter plot of differential expression of the DSTs of Foxp3. The x-axis is the genotype for SNP rs3790904 - Latrophilin homolog 1
(Lphh1/Lphn2). The SNP genotype is also coded as number of minor alleles. The y-axis is the log 2 gene expression. The green dots are the expression
from colony stimulating factor 2 (Csf2) and the blue dots are the expression from interleukin 2 (Il2). The Pearson correlation of the expression from
Csf2 and Il2 is +0.56.
doi:10.1371/journal.pone.0034286.g006
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PLoS ONE | www.plosone.org 10 March 2012 | Volume 7 | Issue 3 | e34286value for a score was determined from a non-parametric
distribution of correlation scores obtained from random cases
(B=10,000 reshuffles of the genes) and the number of times (n) one
of these permuted scores is greater than the observed correlation
score. Thus, p{value~n=B: For both correlation scores, GCS
and EGCS, this null hypothesis keeps the structure and overlap of
all pathways fixed, but changes the identity of the genes.
TReQTL Analysis
For each population and TR, we performed a genome-wide
scan by regressing the log2 expression levels of the DSTs on each
SNP genotype (Z) (coded 0, 1, and 2 representing the number of
minor alleles) separately across the genome. The following
multivariate linear regression (MVR) model was used
Yij~b0jzZib1jzeij ð3Þ
where Yij denotes the log2 expression levels of the DST j (j=1,…,
m) for a TR for subject i (i=1,…,n), m is the number of DSTs of
the TR, Zi is a SNP genotype, a ˚ij is an error and ei=(ei1,…, eim)
follows a multivariate normal distribution with mean 0 and
covariance S. To test for the null hypothesis of association
between a SNP and a TR, we performed the likelihood ratio test
for testing the null hypothesis H0: b11=…=b1m=0, which follows
a chi-square distribution with m degrees of freedom for m,n. Let
the chi-square test statistic D=22(ln(likelihood null model)–
ln(likelihood full model)) where the null model is the MVR model
without the genotypes corresponding to the SNP and the full
model is the MVR model with the genotypes corresponding to the
Figure 7. Foxp3 TReQTL network. The interaction network was generated by Ingenuity Pathway Analysis (IPA) software. Based on the IPA curated
knowledgebase dashed lines represent indirect interactions and solid lines denote direct interactions. The arrow represents the process of acting on a
target. Vertical rectangles are G-protein couple receptors, ovals are transcription regulators, squares are cytokines, double circles are complexs/
groups and single circles are other types of biological molecules. Shaded nodes represent genes of molecules from the TReQTL for Foxp3 (those that
the SNPs map to, the DSTs and the TR).
doi:10.1371/journal.pone.0034286.g007
Table 4. Over-representation of TReQTL SNPs in genomic
regions.
Genomic Region CEU YRI
5-way Conservation 0.006 0.900
17-way Conservation 0.071 0.870
Splice Junctions 0.893 1.0E-04
10 K permutations of 472 SNPs with a p-value,1610
24 in either CEU or YRI.
doi:10.1371/journal.pone.0034286.t004
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PLoS ONE | www.plosone.org 11 March 2012 | Volume 7 | Issue 3 | e34286SNP. The p-value for each association of a SNP and set of DSTs
for a TR was obtained from the distribution of D<x
2 with degrees
of freedom=m. For cases where m.=n, an approximate F-
statistic [9,35,36] was used in order to avoid situations where the
covariance matrix from the MVR model is not full rank. In these
cases, the p-value for statistical significance of each association of a
SNP and a set of DSTs for a TR was assessed by permuting the n
rows and n columns of the F-statistic G (Gower’s centered) matrix
(1610
6 times) and determining the number of times one of these
bootstrapped scores is greater than the observed score. We fit
model (3) by regressing the DSTs of a TR on each SNP separately
across the genome. For multiple testing correction, we used the
6.1610
7 p-values from the regression of the DSTs of the 333 TRs
on the 184,616 independent (tag) SNPs that are within 1 kb of a
gene (cis-acting set) to control the FDR [71] at 45%.
SNP Set Enrichment Analysis
To determine whether a set of SNPs representing TReQTLs
are enriched within the genome, a variation of gene set
enrichment analysis [72] was used. Rather than enrich for SNPs
within pathways as previously described [42], we test for
enrichment of SNPs within particular genomic regions. The
regions of interest are either evolutionary conserved regions
(ECRs) or splice junctions (SJs). The rationale is that variants
which are related to gene expression differences between
populations are more likely to be in genomic regions conserved
across species and\or possibly involved in regulating transcription
by altering splice forms of transcript messages. The ECRs are from
5-way (human, mouse, chimp, rhesus monkey and dog) and 17-
way (human, chimp, macaque, mouse, rat, rabbit, dog, cow,
armadillo, elephant, tenrec, opossum, chicken, frog, zebrafish,
Teraodon, and Fugu) conservation scores for the +/2 20 kbp
flanking regions of the genes. Overlapping chromosomal location
intervals for phastCon scores [73] were segmented and the highest
conservation score within the interval was obtained. SJs were
mapped using Tophat [67]. Transcript abundance was calculated
by Cufflinks [68] and normalized using FPKM [69] (see the
RNA-Seq methods section). For each TR, given a combined set L
of SNPs associated with significant TReQTLs within the CEU or
YRI population, their corresponding p-values and the +1o r21
indication (flag) of the assignment of the SNP either within or not
within genomic region set Si, an enrichment score (ES) is obtained
by the ranking of the SNPs in ascending order (most significant to
least significant), and then summing up the assignment flags. The
ES is calculated by screening this list from the top to the bottom
and increasing (decreasing) a running sum Kolmogorov–Smirnov-
like statistic [72] when encountering or not encountering a SNP in
a genomic region. A normalized ES (NES) is obtained by
accounting for the size of the genomic region set Si. The p-value
for enrichment was determined from a non-parametric distribu-
tion of NESs obtained from random cases (10,000 reshuffles of
the assignment of the SNP (either within or not within a genomics
region)) and the number of times one of these permuted scores is
greater than the observed NES. Significance of enrichment was
also confirmed using a two-tailed Fisher’s exact (parametric) test.
Ranking of the TReQTL SNPs
TherankingofTReQTLSNPs wasperformedbyfirstmeasuring
the cohesion of GO biological process terms in TReQTL i:
ai~
mi
Ni Ni{1 ðÞ
2
ð4Þ
where Ni is the number of nodes (biological process terms)
represented in TReQTLi and mi is the number of the edges
between nodes. The edges were derived from the structure of GO
subtree for each TReQTLi created from the biological process
terms of the gene that the SNP maps to or is in close proximity,
those of the TRs (excluding miRNAs) and the DST genes. The
cohesion measure ai is then weighted by the p-value of TReQTLi to
give a weighted rank. The weight is computed as 22log10(p-value).
Finally, the number of paths and the number of biological process
terms within the subtree were used to derive of the adjusted
cohesion score
ACSi~
ai {2log10(p{valuei) ðÞ Ni=Mi
  
Pi=Ni
   ð5Þ
where for the ith TReQTL, Mi is the maximum number of paths of
a biological process term and Pi is the number of paths.
Gene Interaction Network
Ingenuity Pathway Analysis (IPA) software version 8.8 and
canonical pathway content version 3204 were used to build gene
interactions from Foxp3, its DSTs (CSF2 and Il2) and the
significant TReQTL genes from CEU and mapped on chromo-
some 1 (KCNJ1, LPHN2 and LPHN3).
Supporting Information
Table S1 The TReQTLs for the CEU and YRI populations.
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